Publications

Advocacy

White paper for Dutch Embassy ‘Unlocking the full potential of cancer treatments using targeted radionuclide therapy through Netherlands-UK partnerships’, 2024

Research publications

2024

  1. PMD Gape, MK Schultz, GJ Stasiuk, SYA Terry. Towards effective targeted alpha therapy for neuroendocrine tumors: a review. Pharmaceuticals. 2024 17(3):334.

  2. L Whittaker, JA Dean, C Veiga, S Langdon, R Drake, D Taylor, M-C Williams, H Masters, A Britton, M Cumbo, N Burdis, K Mason, G Fay, E Smith, S Benson, A Halil, S Lambert, MN Gaze, J Gains, B Spencer, A Taylor-Gee, SYA Terry. Radiation Reveal: moving from research engagement to involvement. Br J Cancer 2024; In press.

    2023

  3. LM. Smith, HE Greenwood, WE Tyrrell, RS Edwards, V De Santis, F Baark, G Firth, M Tanc, SYA Terry, A Herrmann, R Southworth, TH Witney. The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging. Npj Imaging 2023; 1:1

  4. KM Wulfmeier, J Cheng, IM Costa, A Rigby, L Livieratos, R Fernandez, PJ Blower, KA Vallis, RM Reilly, G Pirovano, SYA Terry. Radiopharmaceutical Therapy: Auger Electron-Emitting Radionuclides in Radiopharmaceutical Therapy. Switzerland: Springer Cham; 2023.

  5. J Bolcaen, M Gizawy, SYA Terry, A Paulo, B Cornelissen, A Korde, JW Engle, V Radchenko, and RW Howell. Marshalling the potential of Auger electron radiopharmaceutical therapy. J Nuc Med 2023; 64(9):1344-1351.

  6. Nonnekens J, Cornellisen B, Terry S. Second symposium of the European working group on the radiobiology of molecular radionuclide therapy. J Nuc Med 2023; 64:1–3.

  7. Ekmekcioglu O, Terry S, Morbelli S, Cerci J, Damgard Zacho H, Peters S and Boulvard X, Verzijlbergen F. Superfluous, controversial and luxury issues in nuclear medicine. EJNMMI 2023; 50:2582–2587.

    2022

  8. *Rigby A, Firth G, Rivas C, Pham T, Kim J, Phanopoulos A, Wharton L, Ingham A, Li L, Ma MT, Orvig C, Blower PJ, Terry SYA, and Abbate V. Towards bifunctional chelators for thallium-201 for use in nuclear medicine. Bioconjugate Chemistry. Bioconjugate Chem. 2022, 33, 7, 1422–1436

  9. *Nonnekens J, Pouget J-P, Cornelissen B, Terry SYA. Status of radiobiology in molecular radionuclide therapy – hope for the future. Nuc Med Biol. 2022 110-111:45-46.

  10. *Drake R, Terry SYA, Langdon S. Lise Meitner, the scientist who changed medicine by splitting atoms. Front. Young Minds. 2022 10:722112.

    2021

  11. *Costa IM, Siksek N, Volpe A, Man F, Osytek KM, Verger E, Schettino G, Fruhwirth GO and Terry SYA. Relationship of in vitro toxicity of technetium-99m to subcellular localisation and absorbed dose. Int. J. Mol. Sci. 2021 22(24), 13466.

  12. I Hungnes, F Al Salemee, P Gawne, T Eykyn, A Atkinson, SYA Terry, F Clarke; PJ Blower, P Pringle, MT Ma. One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for 99mTc radiolabelling of peptides. Dalton Transactions. 2021 50, 16156-16165.

  13. *EHJG Aarntzen, E Noriega-Álvarez, V Artiko, AH Dias, O Gheysens, AWJM Glaudemans, C Lauri, G Treglia,T van den Wyngaert, FWB van Leeuwen, SYA Terry. EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases. EJNMMI Res. 2021 11:85.

  14. *Verger E, Cheng J, de Santis V, Iafrate M, Jackson JA, Imberti C, Fruhwirth GO, Blower PJ, Ma MT, Burnham DR, Terry SYA. Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy. Nuc Med Biol. 2021 100-101:36-43.

  15. *Osytek KM, Blower PJ, Costa IM, Smith G, Abbate V and Terry SYA. In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201 (201Tl). EJNMMI Res. 2021 11:63.

  16. Cornelissen B, Terry SYA, Nonnekens J, Pouget J-P. First Symposium of the European Working Group on the Radiobiology of Molecular RadioTherapy. J Nuc Med. 2021 62(7):14N-15N.

  17. Blower PJ, Cusnir R, Darwesh A, Long NJ, Ma MT, Osborne BE, Price TW, Reid G, Southworth R, Stasiuk GJ, Terry SYA, de Rosales RTM. Gallium: New developments and applications in radiopharmaceutics. Advances in Inorganic Chemistry. 2021 78:1-35.

  18. *Costa, IM, Cheng J, Osytek K, Imberti C, Terry SYA. Methods and techniques of in vitro subcellular localization of radiopharmaceuticals and radionuclides. Nuc Med Biol. 2021 98-99:18-29.

  19. *Rigby A, Blower JE, Blower PJ, Terry SYA (co-last author), Abbate V. Targeted Auger electron-emitter therapy: radiochemical approaches for thallium-201 radiopharmaceuticals. Nuc Med Biol.2021 98-99:1-7.

    2020

  20. *Keeling GP, Sherin B, Kim J, San Juan B, Grus T, Eykyn TR, Rösch F, Smith GE, Blower PJ, Terry SYA, T M de Rosales R. [68Ga]Ga-THP-Pam: A Bisphosphonate PET Tracer with Facile Radiolabeling and Broad Calcium Mineral Affinity. Bioconjug Chem. 2020 Aug 27. 32(7):1276–1289..

  21. Yardimci S, Burnham DR, Terry SYA, Yardimci H. Three-dimensional super-resolution fluorescence imaging of DNA. Sci Rep. 2020 Jul 27;10(1):12504.

  22. Lobeek D, Rijpkema M, Terry SYA, Molkenboer-Kuenen JDM, Joosten L, van Genugten EAJ, van Engen-van Grunsven ACH, Kaanders JHAM, Pegge SAH, Boerman OC, Weijs WLJ, Merkx MAW, van Herpen CML, Takes RP, Aarntzen EHJG, Oyen WJG. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2647-2655.

  23. Imberti C, Adumeau P, Blower JE, Al Salemee F, Baguña Torres J, Lewis JS, Zeglis BM, Terry SYA, Blower PJ. Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance. Int J Mol Sci. 2020 Feb 22;21(4):1496. 

  24. Lobeek D, Bouwman FCM, Aarntzen EHJG, Molkenboer-Kuenen JDM, Flucke UE, Nguyen HL, Vikkula M, Boon LM, Klein W, Laverman P, Oyen WJG, Boerman OC, Terry SYA, Schultze Kool LJ, Rijpkema M. A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT. J Nucl Med. 2020 Feb;61(2):270-275.

  25. *Gawne PJ, Clarke F, Turjeman K, Cope AP, Long NJ, Barenholz Y, Terry SYA, de Rosales RTM. PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis. Theranostics. 2020 Feb 26;10(9):3867-3879.

  26. *Othman MFB, Verger E, Costa I, Tanapirakgul M, Cooper MS, Imberti C, Lewington VJ, Blower PJ, Terry SYA. In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab. Nucl Med Biol. 2020 Jan-Feb;80-81:57-64. 8TH MOST DOWNLOADED OF ALL TIME AT NUC MED BIOL (DEC 2020)

  27. O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy. J Nucl Med. 2020 May;61(5):743-750.

    2019

  28. Falzone N, Gregory R, Aldridge M, Terry SY, Flux G. Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018. Br J Radiol. 2019 Aug;92(1100):20190117. 

  29. *Terry SYA, Nonnekens J, Aerts A, Baatout S, de Jong M, Cornelissen B, Pouget JP. Call to arms: need for radiobiology in molecular radionuclide therapy. Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1588-1590. 

    2018

  30. Falzone N, Lee BQ, Able S, Malcolm J, Terry S, Alayed Y, Vallis KA. Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability. J Nucl Med. 2018 Jun 29;60(2):250–8. 

  31. *Lobeek D, Franssen GM, Ma MT, Wester HJ, Decristoforo C, Oyen WJG, Boerman OC, Terry SYA, Rijpkema M. In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image αvβ3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models. J Nucl Med. 2018 Aug;59(8):1296-1301.

    2017

  32. Young JD, Abbate V, Imberti C, Meszaros LK, Ma MT, Terry SYA, Hider RC, Mullen GE, Blower PJ. 68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling. J Nucl Med. 2017 Aug;58(8):1270-1277.

  33. *van der Meer LT, Terry SY, van Ingen Schenau DS, Andree KC, Franssen GM, Roeleveld DM, Metselaar JM, Reinheckel T, Hoogerbrugge PM, Boerman OC, van Leeuwen FN. In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow. J Nucl Med. 2017 Feb;58(2):214-220.

  34. Imberti C, Terry SY, Cullinane C, Clarke F, Cornish GH, Ramakrishnan NK, Roselt P, Cope AP, Hicks RJ, Blower PJ, Ma MT. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. Bioconjug Chem. 2017 Feb 15;28(2):481-495. 

  35. *Othman MF, Mitry NR, Lewington VJ, Blower PJ, Terry SY. Re-assessing gallium-67 as a therapeutic radionuclide. Nucl Med Biol. 2017 Mar;46:12-18.

    2016

  36. *Terry SY, Koenders MI, Franssen GM, Nayak TK, Freimoser-Grundschober A, Klein C, Oyen WJ, Boerman OC, Laverman P. Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3. J Nucl Med. 2016 Mar;57(3):467-72.

  37. Ma MT, Cullinane C, Imberti C, Baguña Torres J, Terry SY, Roselt P, Hicks RJ, Blower PJ. New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). Bioconjug Chem. 2016 Feb 17;27(2):309-18.

    2015

  38. O'Neill AS, Terry SY, Brown K, Meader L, Wong AM, Cooper JD, Crocker PR, Wong W, Mullen GE. Non-invasive molecular imaging of inflammatory macrophages in allograft rejection. EJNMMI Res. 2015 Dec;5(1):69. 

  39. *Terry SY, Boerman OC, Gerrits D, Franssen GM, Metselaar JM, Lehmann S, Oyen WJ, Gerdes CA, Abiraj K. ¹¹¹In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages. Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1430-8. 

  40. Laverman P, van der Geest T, Terry SY, Gerrits D, Walgreen B, Helsen MM, Nayak TK, Freimoser-Grundschober A, Waldhauer I, Hosse RJ, Moessner E, Umana P, Klein C, Oyen WJ, Koenders MI, Boerman OC. Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis. J Nucl Med. 2015 May;56(5):778-83. 

    2014

  41. *Terry SY, Abiraj K, Lok J, Gerrits D, Franssen GM, Oyen WJ, Boerman OC. Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts? J Nucl Med. 2014 Nov;55(11):1849-55. 

  42. *Terry SY, Abiraj K, Frielink C, van Dijk LK, Bussink J, Oyen WJ, Boerman OC. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts. J Nucl Med. 2014 Feb;55(2):281-6.

  43. *Terry SY, Rijpkema M, Abiraj K, van der Graaf WT, Oyen WJ, Boerman OC. Radiolabeled imaging probes targeting angiogenesis for personalized medicine. Curr Pharm Des. 2014;20(14):2293-307.

    2013

  44. *Dijkgraaf I, Terry SY, McBride WJ, Goldenberg DM, Laverman P, Franssen GM, Oyen WJ, Boerman OC. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide. Contrast Media Mol Imaging. 2013 May-Jun;8(3):238-45. 

    2012

  45. *Terry SY, Vallis KA. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1298-305.

    2010

  46. *Bryant PE, Riches AC, Terry SY. Mechanisms of the formation of radiation-induced chromosomal aberrations. Mutat Res. 2010 Aug 14;701(1):23-6. 

    2009

  47. *Terry SY, Riches AC, Bryant PE. Suppression of topoisomerase IIalpha expression and function in human cells decreases chromosomal radiosensitivity. Mutat Res. 2009 Apr 26;663(1-2):40-5.

    2008

  48. *Terry SY, Riches AC, Bryant PE. A role for topoisomerase II alpha in the formation of radiation-induced chromatid breaks. Br J Cancer. 2008 Aug 19;99(4):670-4.